Further studies that evaluated markers as continuous variables demonstrated that the expression intensities of antigens CD13, CD56, CD64, CD117, and myeloperoxidase are significantly different between APL and non-APL AML. The gene discussed is MPO; the disease is acute myeloid leukemia.